Acta Pharmaceutica Sinica B

Published by Elsevier

Open access · CC BY-NC-ND · In DOAJ · Kingdom of the Netherlands · Nanoplatforms for cancer theranostics

Journal at a glance

ISSN

2211-3835

Publisher

Elsevier

Country

Kingdom of the Netherlands

Language

en

License

CC BY-NC-ND

Also known as: Acta Pharm Sin B (Abbreviation), APSB (Alternate title)

Indexing

• Web of Science (SCIE): Indexed
• DOAJ: Active
• Pubmed: Active

Metrics

Subjects

• Nanoplatforms for cancer theranostics
• Nanoparticle-Based Drug Delivery
• RNA Interference and Gene Delivery
• Diverse Scientific and Economic Studies
• Immunotherapy and Immune Responses
• Ferroelectric and Negative Capacitance Devices
• Big Data and Digital Economy
• Medicine: Therapeutics. Pharmacology
• Therapeutics. Pharmacology

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition (2026)
• Unveiling the mechanisms of comorbidity of aging and depression: A perspective based on early life stress (ELS) (2026)
• Lipid nanoparticle co-delivery of siRNA silencing P-glycoprotein overcomes Camptothecin resistance in an acute lymphoblastic leukemia model (2026)
• Antibody peptide conjugates as multifunctional therapeutics: Mechanisms, challenges, and prospects (2026)
• Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity (2026)

Similar journals

• Pharmaceutical nanotechnology — Kingdom of the Netherlands · — · Same subject: Diverse Scientific and Economic Studies, Same subject: Nanoparticle-Based Drug Delivery, 3 shared subjects in total, Same country
• Biomaterials — United Kingdom · — · Same subject: Nanoparticle-Based Drug Delivery, Same subject: Nanoplatforms for cancer theranostics, 3 shared subjects in total
• Nature biomedical engineering — United Kingdom · — · Same subject: Immunotherapy and Immune Responses, Same subject: Nanoplatforms for cancer theranostics, 3 shared subjects in total
• Therapeutic delivery — United Kingdom · — · Same subject: Nanoparticle-Based Drug Delivery, Same subject: Nanoplatforms for cancer theranostics, 3 shared subjects in total
• Kansas journal of medicine — United States · Open access · Same subject: Big Data and Digital Economy, Same subject: Diverse Scientific and Economic Studies, 3 shared subjects in total
• European journal of nanomedicine — Germany · — · Same subject: Nanoparticle-Based Drug Delivery, Same subject: Nanoplatforms for cancer theranostics, 3 shared subjects in total

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate) · Last verified 2026-09-05

Journal homepage · Author guidelines